Caribou Biosciences (CRBU) Depreciation and Depletion (2020 - 2022)
Caribou Biosciences (CRBU) reported Depreciation and Depletion of $400000.0 for Q2 2022, up 100.0% year-over-year from $200000.0 in Q2 2021, and up 33.33% quarter-over-quarter from $300000.0 in Q1 2022.
Caribou Biosciences (CRBU) Depreciation and Depletion (2020 - 2022) Analysis & Trends
Caribou Biosciences (CRBU) has 3 years of Depreciation and Depletion data on file, last reported at $400000.0 in Q2 2022.
- Depreciation and Depletion for Q2 2022 came in at $400000.0, up 100.0% year-over-year; the trailing twelve-month figure through Jun 2022 was $301000.0 (down 66.56% YoY), and the FY2021 annual result was $1000.0, down 99.89% from the prior year.
- Depreciation and Depletion rose to $400000.0 in Q2 2022 per CRBU's latest filing, from $300000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $400000.0 in Q2 2022 and troughed at -$699000.0 in Q4 2021.
- A 3-year average of $155666.7 and a median of $200000.0 in 2020 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2021 and 2022: Depreciation and Depletion slumped 449.5% in 2021, then jumped 100.0% in 2022.
- A 3-year view of Depreciation and Depletion shows it stood at $200000.0 in 2020, then tumbled by 449.5% to -$699000.0 in 2021, then soared by 157.22% to $400000.0 in 2022.
- Business Quant data shows CRBU's Depreciation and Depletion at $400000.0 in Q2 2022, $300000.0 in Q1 2022, and -$699000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Caribou Biosciences | 156.73 Mn | 39.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 400,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | -699,000.00 |
| Dec 31, 2021 | -699,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 200,000.00 |
| Mar 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 200,000.00 |
| Jun 30, 2020 | 200,000.00 |